Drugs / Loestrin
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 13 trials | ||||||
| Phase 1 | NCT06310616 | Mar → Aug 2024 | HIV infectious disease | ViiV Healthcare | Completed | No outcome recorded |
| Phase 1 | NCT03451110 | Feb → Mar 2018 | — | Eisai Inc. | Completed | No outcome recorded |
| Phase 1 | NCT03262727 | Sep → Nov 2017 | inflammatory bowel disease, psoriasis, psoriatic arthritis, systemic lupus erythematosus | Bristol-Myers Squibb | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00125983 | ? → Jan 2007 | HIV infectious disease, pregnancy disorder | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT05891262 Background | Jun → Aug 2023 | — | Bristol-Myers Squibb | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01200537 Comparator | Oct 2010 → Oct 2011 | female infertility due to oocyte meiotic arrest | Duke University | Withdrawn | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Loestrin | “Loestrin” NCT01200537 ↗ |
| Known as | ON 1/35 | “The purpose of the study is to examine the interaction between a PI-based regimen containing LPV/r and two forms of contraceptive medications, Ortho Evra and an oral...” NCT00125983 ↗ |
| Known as | Ortho-Novum | “Ortho-Novum” NCT01200537 ↗ |
| Route | Oral | “the interaction between a PI-based regimen containing LPV/r and two forms of contraceptive medications, Ortho Evra and an oral contraceptive, Ortho Novum (ON 1/35), in HIV...” NCT00125983 ↗ |